IVIg Reduces Infection Rate in Multiple Myeloma Patients Receiving Anti-BCMA Therapy

THURSDAY, Oct. 5, 2023 -- Many patients with multiple myeloma treated with anti-B cell maturation antigen (BCMA) therapy have infections, and the rate of infections is significantly lower when patients are receiving intravenous immunoglobulin,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news